DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

Ovid Therapeutics Q4 EPS $(0.35) Up From $(0.52) YoY

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.35) per share. This is a 32.69 percent increase over losses of $(0.52) per share from the same period last year.

Benzinga · 03/11/2020 12:13

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.35) per share. This is a 32.69 percent increase over losses of $(0.52) per share from the same period last year.